We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPR
151
DELISTED
Spirit AeroSystems
SPR
| $8.55M | 0.03% |
292,772
-1,000
| -0.3% | -$28.8K |
|
152
Lennar Class A
LEN
$19.8B
| $8.53M | 0.03% |
70,312
-11,502
| -14% | -$1.26M |
|
153
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $8.31M | 0.03% |
179,862
+1,027
| +0.6% | +$47.2K |
|
154
CBIZ
CBZ
$2.16B
| $8.29M | 0.03% |
155,635
-36,895
| -19% | -$1.9M |
|
155
Costco
COST
$411B
| $8.27M | 0.03% |
15,354
-309
| -2% | -$156K |
|
156
Enterprise Products Partners
EPD
$83.9B
| $8.13M | 0.03% |
308,370
-403
| -0.1% | -$10.5K |
|
157
Walmart Inc
WMT
$863B
| $8.12M | 0.03% |
155,061
-3,552
| -2% | -$179K |
|
158
Caleres
CAL
$392M
| $8.11M | 0.03% |
339,110
-23,350
| -6% | -$523K |
|
159
Consolidated Water Co
CWCO
$469M
| $8.04M | 0.03% |
331,882
-18,820
| -5% | -$364K |
|
160
Evergy
EVRG
$20B
| $8.02M | 0.03% |
137,309
-12,948
| -9% | -$782K |
|
161
Travelers Companies
TRV
$78.5B
| $8.02M | 0.03% |
46,182
-2,674
| -5% | -$472K |
|
162
Ameriprise Financial
AMP
$46B
| $7.94M | 0.03% |
23,917
-3,125
| -12% | -$960K |
|
163
Arthur J. Gallagher & Co
AJG
$62.2B
| $7.87M | 0.03% |
35,853
-1,210
| -3% | -$252K |
|
164
Essential Utilities
WTRG
$11.2B
| $7.8M | 0.03% |
195,514
-10,928
| -5% | -$459K |
|
165
Capital Southwest
CSWC
$1.46B
| $7.76M | 0.03% |
393,378
-7,929
| -2% | -$146K |
|
166
McCormick & Company Non-Voting
MKC
$13.5B
| $7.63M | 0.03% |
87,507
-4,800
| -5% | -$424K |
|
167
Otis Worldwide
OTIS
$27.2B
| $7.6M | 0.03% |
85,360
-4,361
| -5% | -$367K |
|
|
VBTX
168
DELISTED
Veritex Holdings
VBTX
| $7.5M | 0.03% |
418,173
+33,599
| +9% | +$598K |
|
|
169
PNC Financial Services
PNC
$99.5B
| $7.49M | 0.03% |
59,463
-243,943
| -80% | -$29.8M |
|
170
SLB Ltd
SLB
$70.6B
| $7.45M | 0.03% |
151,624
-7,279
| -5% | -$347K |
|
171
Delta Air Lines
DAL
$53.9B
| $7.35M | 0.03% |
154,529
-14,451
| -9% | -$533K |
|
172
NVIDIA
NVDA
$5.06T
| $7.28M | 0.03% |
172,210
+3,550
| +2% | +$118K |
|
173
NorthWestern Energy
NWE
$4.46B
| $7.24M | 0.03% |
127,582
-7,763
| -6% | -$454K |
|
174
Coty
COTY
$2.29B
| $7.18M | 0.03% |
583,897
-75,750
| -11% | -$894K |
|
175
Rezolute
RZLT
$511M
| $7.17M | 0.03% |
3,623,078
+500,000
| +16% | +$1.03M |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.